nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—liver cancer—rectum cancer	0.345	0.395	CtDrD
Doxorubicin—urinary bladder cancer—rectum cancer	0.276	0.317	CtDrD
Doxorubicin—stomach cancer—rectum cancer	0.251	0.288	CtDrD
Doxorubicin—NOS1—myenteric nerve plexus—rectum cancer	0.00846	0.0815	CbGeAlD
Doxorubicin—NOS1—penis—rectum cancer	0.0048	0.0462	CbGeAlD
Doxorubicin—NOS3—vein—rectum cancer	0.00415	0.0399	CbGeAlD
Doxorubicin—NOS3—penis—rectum cancer	0.00365	0.0351	CbGeAlD
Doxorubicin—AURKA—PLK1 signaling events—RAB1A—rectum cancer	0.00231	0.0961	CbGpPWpGaD
Doxorubicin—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0022	0.0915	CbGpPWpGaD
Doxorubicin—SLC22A16—renal system—rectum cancer	0.00178	0.0172	CbGeAlD
Doxorubicin—CBR3—seminal vesicle—rectum cancer	0.00166	0.016	CbGeAlD
Doxorubicin—SLC22A16—female reproductive system—rectum cancer	0.00143	0.0138	CbGeAlD
Doxorubicin—ABCB8—renal system—rectum cancer	0.00139	0.0134	CbGeAlD
Doxorubicin—CBR3—urethra—rectum cancer	0.00131	0.0126	CbGeAlD
Doxorubicin—AKR1A1—seminal vesicle—rectum cancer	0.00128	0.0123	CbGeAlD
Doxorubicin—CBR3—mammalian vulva—rectum cancer	0.00125	0.012	CbGeAlD
Doxorubicin—ABCB8—female reproductive system—rectum cancer	0.00111	0.0107	CbGeAlD
Doxorubicin—AKR1A1—smooth muscle tissue—rectum cancer	0.00107	0.0103	CbGeAlD
Doxorubicin—CBR3—female reproductive system—rectum cancer	0.00107	0.0103	CbGeAlD
Doxorubicin—AKR1A1—renal system—rectum cancer	0.00103	0.00993	CbGeAlD
Doxorubicin—AKR1A1—urethra—rectum cancer	0.00101	0.00975	CbGeAlD
Doxorubicin—SLC22A16—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.001	0.0416	CbGpPWpGaD
Doxorubicin—RALBP1—RalA downstream regulated genes—NRAS—rectum cancer	0.000979	0.0407	CbGpPWpGaD
Doxorubicin—CBR3—vagina—rectum cancer	0.000967	0.00931	CbGeAlD
Doxorubicin—AKR1A1—mammalian vulva—rectum cancer	0.000964	0.00928	CbGeAlD
Doxorubicin—NDUFS2—seminal vesicle—rectum cancer	0.000963	0.00928	CbGeAlD
Doxorubicin—NDUFS3—seminal vesicle—rectum cancer	0.000951	0.00916	CbGeAlD
Doxorubicin—NDUFS7—renal system—rectum cancer	0.000937	0.00902	CbGeAlD
Doxorubicin—DHCR7—seminal vesicle—rectum cancer	0.000904	0.00871	CbGeAlD
Doxorubicin—AURKA—renal system—rectum cancer	0.000871	0.00839	CbGeAlD
Doxorubicin—RALBP1—RalA downstream regulated genes—KRAS—rectum cancer	0.000843	0.0351	CbGpPWpGaD
Doxorubicin—NOS1—epithelium—rectum cancer	0.000842	0.00811	CbGeAlD
Doxorubicin—YWHAG—seminal vesicle—rectum cancer	0.000829	0.00799	CbGeAlD
Doxorubicin—AKR1A1—female reproductive system—rectum cancer	0.000825	0.00795	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000822	0.0342	CbGpPWpGaD
Doxorubicin—AURKA—mammalian vulva—rectum cancer	0.000814	0.00784	CbGeAlD
Doxorubicin—NOS1—smooth muscle tissue—rectum cancer	0.000811	0.00781	CbGeAlD
Doxorubicin—NDUFS2—smooth muscle tissue—rectum cancer	0.000806	0.00776	CbGeAlD
Doxorubicin—NDUFS3—smooth muscle tissue—rectum cancer	0.000796	0.00767	CbGeAlD
Doxorubicin—NOS1—renal system—rectum cancer	0.000781	0.00752	CbGeAlD
Doxorubicin—NDUFS2—renal system—rectum cancer	0.000776	0.00747	CbGeAlD
Doxorubicin—NDUFS3—renal system—rectum cancer	0.000767	0.00738	CbGeAlD
Doxorubicin—NDUFS2—urethra—rectum cancer	0.000762	0.00734	CbGeAlD
Doxorubicin—NDUFS3—urethra—rectum cancer	0.000753	0.00725	CbGeAlD
Doxorubicin—NDUFS7—female reproductive system—rectum cancer	0.00075	0.00722	CbGeAlD
Doxorubicin—RALBP1—seminal vesicle—rectum cancer	0.000749	0.00721	CbGeAlD
Doxorubicin—AKR1A1—vagina—rectum cancer	0.000747	0.00719	CbGeAlD
Doxorubicin—NDUFS2—mammalian vulva—rectum cancer	0.000726	0.00699	CbGeAlD
Doxorubicin—NDUFS3—mammalian vulva—rectum cancer	0.000717	0.0069	CbGeAlD
Doxorubicin—RALBP1—RalA downstream regulated genes—HRAS—rectum cancer	0.000716	0.0298	CbGpPWpGaD
Doxorubicin—DHCR7—urethra—rectum cancer	0.000716	0.00689	CbGeAlD
Doxorubicin—ABCC6—renal system—rectum cancer	0.00071	0.00684	CbGeAlD
Doxorubicin—CBR1—seminal vesicle—rectum cancer	0.000699	0.00673	CbGeAlD
Doxorubicin—AURKA—female reproductive system—rectum cancer	0.000697	0.00672	CbGeAlD
Doxorubicin—YWHAG—smooth muscle tissue—rectum cancer	0.000694	0.00669	CbGeAlD
Doxorubicin—AKR1C3—seminal vesicle—rectum cancer	0.000691	0.00665	CbGeAlD
Doxorubicin—DHCR7—mammalian vulva—rectum cancer	0.000681	0.00656	CbGeAlD
Doxorubicin—NDUFS7—vagina—rectum cancer	0.000678	0.00653	CbGeAlD
Doxorubicin—YWHAG—renal system—rectum cancer	0.000668	0.00644	CbGeAlD
Doxorubicin—YWHAG—urethra—rectum cancer	0.000657	0.00632	CbGeAlD
Doxorubicin—XDH—renal system—rectum cancer	0.000652	0.00628	CbGeAlD
Doxorubicin—ABCB8—lymph node—rectum cancer	0.00065	0.00626	CbGeAlD
Doxorubicin—NOS3—epithelium—rectum cancer	0.00064	0.00617	CbGeAlD
Doxorubicin—AURKA—vagina—rectum cancer	0.000631	0.00607	CbGeAlD
Doxorubicin—POR—seminal vesicle—rectum cancer	0.000631	0.00607	CbGeAlD
Doxorubicin—RALBP1—smooth muscle tissue—rectum cancer	0.000627	0.00604	CbGeAlD
Doxorubicin—NOS1—female reproductive system—rectum cancer	0.000626	0.00602	CbGeAlD
Doxorubicin—CBR3—lymph node—rectum cancer	0.000625	0.00602	CbGeAlD
Doxorubicin—YWHAG—mammalian vulva—rectum cancer	0.000625	0.00602	CbGeAlD
Doxorubicin—NDUFS2—female reproductive system—rectum cancer	0.000622	0.00599	CbGeAlD
Doxorubicin—NOS3—smooth muscle tissue—rectum cancer	0.000617	0.00594	CbGeAlD
Doxorubicin—NDUFS3—female reproductive system—rectum cancer	0.000614	0.00591	CbGeAlD
Doxorubicin—XDH—mammalian vulva—rectum cancer	0.00061	0.00587	CbGeAlD
Doxorubicin—RALBP1—renal system—rectum cancer	0.000604	0.00581	CbGeAlD
Doxorubicin—NOS3—renal system—rectum cancer	0.000594	0.00572	CbGeAlD
Doxorubicin—RALBP1—urethra—rectum cancer	0.000593	0.00571	CbGeAlD
Doxorubicin—DHCR7—female reproductive system—rectum cancer	0.000583	0.00562	CbGeAlD
Doxorubicin—AKR1C3—smooth muscle tissue—rectum cancer	0.000578	0.00557	CbGeAlD
Doxorubicin—RALBP1—mammalian vulva—rectum cancer	0.000564	0.00544	CbGeAlD
Doxorubicin—CBR1—renal system—rectum cancer	0.000564	0.00543	CbGeAlD
Doxorubicin—NDUFS2—vagina—rectum cancer	0.000562	0.00541	CbGeAlD
Doxorubicin—NQO1—seminal vesicle—rectum cancer	0.00056	0.0054	CbGeAlD
Doxorubicin—NDUFS3—vagina—rectum cancer	0.000555	0.00535	CbGeAlD
Doxorubicin—CBR1—urethra—rectum cancer	0.000554	0.00533	CbGeAlD
Doxorubicin—AKR1C3—urethra—rectum cancer	0.000547	0.00526	CbGeAlD
Doxorubicin—YWHAG—female reproductive system—rectum cancer	0.000535	0.00516	CbGeAlD
Doxorubicin—DHCR7—vagina—rectum cancer	0.000528	0.00508	CbGeAlD
Doxorubicin—CBR1—mammalian vulva—rectum cancer	0.000527	0.00508	CbGeAlD
Doxorubicin—XDH—female reproductive system—rectum cancer	0.000522	0.00503	CbGeAlD
Doxorubicin—AKR1C3—mammalian vulva—rectum cancer	0.00052	0.00501	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000508	0.0211	CbGpPWpGaD
Doxorubicin—ABCC10—seminal vesicle—rectum cancer	0.0005	0.00482	CbGeAlD
Doxorubicin—POR—urethra—rectum cancer	0.000499	0.00481	CbGeAlD
Doxorubicin—NQO1—epithelium—rectum cancer	0.000487	0.00469	CbGeAlD
Doxorubicin—YWHAG—vagina—rectum cancer	0.000484	0.00466	CbGeAlD
Doxorubicin—RALBP1—female reproductive system—rectum cancer	0.000483	0.00466	CbGeAlD
Doxorubicin—AKR1A1—lymph node—rectum cancer	0.000483	0.00465	CbGeAlD
Doxorubicin—NOS3—female reproductive system—rectum cancer	0.000476	0.00458	CbGeAlD
Doxorubicin—POR—mammalian vulva—rectum cancer	0.000475	0.00458	CbGeAlD
Doxorubicin—XDH—vagina—rectum cancer	0.000472	0.00455	CbGeAlD
Doxorubicin—NQO1—smooth muscle tissue—rectum cancer	0.000469	0.00452	CbGeAlD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000457	0.019	CbGpPWpGaD
Doxorubicin—NQO1—renal system—rectum cancer	0.000451	0.00435	CbGeAlD
Doxorubicin—CBR1—female reproductive system—rectum cancer	0.000451	0.00435	CbGeAlD
Doxorubicin—NQO1—urethra—rectum cancer	0.000444	0.00427	CbGeAlD
Doxorubicin—TOP2A—mammalian vulva—rectum cancer	0.000443	0.00427	CbGeAlD
Doxorubicin—NDUFS7—lymph node—rectum cancer	0.000439	0.00423	CbGeAlD
Doxorubicin—RALBP1—vagina—rectum cancer	0.000437	0.00421	CbGeAlD
Doxorubicin—NOS3—vagina—rectum cancer	0.00043	0.00414	CbGeAlD
Doxorubicin—NQO1—mammalian vulva—rectum cancer	0.000422	0.00407	CbGeAlD
Doxorubicin—CBR1—vagina—rectum cancer	0.000408	0.00393	CbGeAlD
Doxorubicin—AURKA—lymph node—rectum cancer	0.000408	0.00393	CbGeAlD
Doxorubicin—ABCC3—renal system—rectum cancer	0.000405	0.0039	CbGeAlD
Doxorubicin—ABCC10—renal system—rectum cancer	0.000403	0.00388	CbGeAlD
Doxorubicin—AKR1C3—vagina—rectum cancer	0.000403	0.00388	CbGeAlD
Doxorubicin—ABCC10—urethra—rectum cancer	0.000396	0.00381	CbGeAlD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000385	0.016	CbGpPWpGaD
Doxorubicin—ABCC10—mammalian vulva—rectum cancer	0.000377	0.00363	CbGeAlD
Doxorubicin—POR—vagina—rectum cancer	0.000368	0.00354	CbGeAlD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—TYMS—rectum cancer	0.000366	0.0152	CbGpPWpGaD
Doxorubicin—NDUFS2—lymph node—rectum cancer	0.000364	0.0035	CbGeAlD
Doxorubicin—NQO1—female reproductive system—rectum cancer	0.000362	0.00348	CbGeAlD
Doxorubicin—NDUFS3—lymph node—rectum cancer	0.000359	0.00346	CbGeAlD
Doxorubicin—AURKA—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.000358	0.0149	CbGpPWpGaD
Doxorubicin—ABCC1—seminal vesicle—rectum cancer	0.000354	0.00341	CbGeAlD
Doxorubicin—TOP2A—vagina—rectum cancer	0.000343	0.0033	CbGeAlD
Doxorubicin—DHCR7—lymph node—rectum cancer	0.000341	0.00329	CbGeAlD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000337	0.014	CbGpPWpGaD
Doxorubicin—CYP1B1—smooth muscle tissue—rectum cancer	0.000329	0.00317	CbGeAlD
Doxorubicin—NQO1—vagina—rectum cancer	0.000327	0.00315	CbGeAlD
Doxorubicin—ABCC3—female reproductive system—rectum cancer	0.000325	0.00313	CbGeAlD
Doxorubicin—ABCC2—renal system—rectum cancer	0.000324	0.00312	CbGeAlD
Doxorubicin—ABCC10—female reproductive system—rectum cancer	0.000323	0.00311	CbGeAlD
Doxorubicin—AURKA—Cell Cycle—RAB1A—rectum cancer	0.00032	0.0133	CbGpPWpGaD
Doxorubicin—CYP1B1—renal system—rectum cancer	0.000317	0.00305	CbGeAlD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000315	0.0131	CbGpPWpGaD
Doxorubicin—YWHAG—lymph node—rectum cancer	0.000313	0.00302	CbGeAlD
Doxorubicin—ABCG2—seminal vesicle—rectum cancer	0.000293	0.00282	CbGeAlD
Doxorubicin—ABCC10—vagina—rectum cancer	0.000292	0.00281	CbGeAlD
Doxorubicin—RALBP1—lymph node—rectum cancer	0.000283	0.00272	CbGeAlD
Doxorubicin—ABCC1—urethra—rectum cancer	0.00028	0.0027	CbGeAlD
Doxorubicin—NOS3—lymph node—rectum cancer	0.000278	0.00268	CbGeAlD
Doxorubicin—AURKA—Aurora A signaling—TP53—rectum cancer	0.000273	0.0113	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.000271	0.0113	CbGpPWpGaD
Doxorubicin—ABCC1—mammalian vulva—rectum cancer	0.000267	0.00257	CbGeAlD
Doxorubicin—CBR1—lymph node—rectum cancer	0.000264	0.00254	CbGeAlD
Doxorubicin—AKR1C3—lymph node—rectum cancer	0.000261	0.00251	CbGeAlD
Doxorubicin—XDH—Nucleotide metabolism—TYMS—rectum cancer	0.00026	0.0108	CbGpPWpGaD
Doxorubicin—ABCC2—female reproductive system—rectum cancer	0.000259	0.0025	CbGeAlD
Doxorubicin—CYP1B1—female reproductive system—rectum cancer	0.000254	0.00245	CbGeAlD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—TYMS—rectum cancer	0.000252	0.0105	CbGpPWpGaD
Doxorubicin—YWHAG—Activation of BH3-only proteins—TP53—rectum cancer	0.000245	0.0102	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—RAB1A—rectum cancer	0.000243	0.0101	CbGpPWpGaD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—rectum cancer	0.00024	0.00997	CbGpPWpGaD
Doxorubicin—NOS1—Amyotrophic lateral sclerosis (ALS)—TP53—rectum cancer	0.000238	0.00991	CbGpPWpGaD
Doxorubicin—POR—lymph node—rectum cancer	0.000238	0.00229	CbGeAlD
Doxorubicin—ABCG2—urethra—rectum cancer	0.000232	0.00223	CbGeAlD
Doxorubicin—TOP2A—lymph node—rectum cancer	0.000222	0.00214	CbGeAlD
Doxorubicin—ABCG2—mammalian vulva—rectum cancer	0.000221	0.00213	CbGeAlD
Doxorubicin—CYP2B6—renal system—rectum cancer	0.000218	0.0021	CbGeAlD
Doxorubicin—NQO1—lymph node—rectum cancer	0.000212	0.00204	CbGeAlD
Doxorubicin—ABCC1—vagina—rectum cancer	0.000207	0.00199	CbGeAlD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—rectum cancer	0.000206	0.00858	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	0.000198	0.00823	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.000192	0.00799	CbGpPWpGaD
Doxorubicin—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	0.000192	0.00798	CbGpPWpGaD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.000191	0.00794	CbGpPWpGaD
Doxorubicin—ABCC3—lymph node—rectum cancer	0.00019	0.00183	CbGeAlD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00019	0.0079	CbGpPWpGaD
Doxorubicin—ABCC10—lymph node—rectum cancer	0.000189	0.00182	CbGeAlD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—rectum cancer	0.000176	0.0073	CbGpPWpGaD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—rectum cancer	0.000175	0.00729	CbGpPWpGaD
Doxorubicin—CYP2B6—female reproductive system—rectum cancer	0.000174	0.00168	CbGeAlD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—NRAS—rectum cancer	0.000172	0.00714	CbGpPWpGaD
Doxorubicin—ABCG2—vagina—rectum cancer	0.000171	0.00165	CbGeAlD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	0.00017	0.00708	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—RAB1A—rectum cancer	0.00017	0.00706	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.000165	0.00687	CbGpPWpGaD
Doxorubicin—CYP3A4—renal system—rectum cancer	0.000164	0.00158	CbGeAlD
Doxorubicin—CYP2D6—renal system—rectum cancer	0.000162	0.00156	CbGeAlD
Doxorubicin—YWHAG—LKB1 signaling events—TP53—rectum cancer	0.000159	0.00662	CbGpPWpGaD
Doxorubicin—CYP2B6—vagina—rectum cancer	0.000158	0.00152	CbGeAlD
Doxorubicin—ABCC2—lymph node—rectum cancer	0.000152	0.00146	CbGeAlD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	0.000151	0.00629	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	0.000149	0.00621	CbGpPWpGaD
Doxorubicin—CYP1B1—lymph node—rectum cancer	0.000149	0.00143	CbGeAlD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—KRAS—rectum cancer	0.000148	0.00614	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—NRAS—rectum cancer	0.000148	0.00614	CbGpPWpGaD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—rectum cancer	0.000147	0.0061	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	0.000145	0.00602	CbGpPWpGaD
Doxorubicin—TOP2A—Gastric Cancer Network 2—TP53—rectum cancer	0.000145	0.00601	CbGpPWpGaD
Doxorubicin—ABCB1—seminal vesicle—rectum cancer	0.000144	0.00139	CbGeAlD
Doxorubicin—NOS2—Circadian rythm related genes—TYMS—rectum cancer	0.000143	0.00594	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.00014	0.00584	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—ITGA2—rectum cancer	0.00014	0.00581	CbGpPWpGaD
Doxorubicin—TOP2A—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.000134	0.00559	CbGpPWpGaD
Doxorubicin—ABCC1—lymph node—rectum cancer	0.000134	0.00129	CbGeAlD
Doxorubicin—NOS1—Alzheimers Disease—TP53—rectum cancer	0.000133	0.00552	CbGpPWpGaD
Doxorubicin—CYP3A4—female reproductive system—rectum cancer	0.000132	0.00127	CbGeAlD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00013	0.00542	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—NRAS—rectum cancer	0.00013	0.00541	CbGpPWpGaD
Doxorubicin—CYP2D6—female reproductive system—rectum cancer	0.00013	0.00125	CbGeAlD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	0.000128	0.00534	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—KRAS—rectum cancer	0.000127	0.00528	CbGpPWpGaD
Doxorubicin—ABCB1—epithelium—rectum cancer	0.000126	0.00121	CbGeAlD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—HRAS—rectum cancer	0.000126	0.00522	CbGpPWpGaD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—TP53—rectum cancer	0.000121	0.00505	CbGpPWpGaD
Doxorubicin—ABCB1—renal system—rectum cancer	0.000116	0.00112	CbGeAlD
Doxorubicin—ABCB1—urethra—rectum cancer	0.000114	0.0011	CbGeAlD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	0.000114	0.00475	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—KRAS—rectum cancer	0.000112	0.00466	CbGpPWpGaD
Doxorubicin—ABCG2—lymph node—rectum cancer	0.000111	0.00107	CbGeAlD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	0.000109	0.00454	CbGpPWpGaD
Doxorubicin—ABCB1—mammalian vulva—rectum cancer	0.000109	0.00105	CbGeAlD
Doxorubicin—YWHAG—mTOR signaling pathway—HRAS—rectum cancer	0.000108	0.00449	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—ITGA2—rectum cancer	0.000105	0.00438	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.000105	0.00437	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000103	0.0043	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000102	0.00425	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—NRAS—rectum cancer	0.000102	0.00423	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000102	0.00423	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TYMS—rectum cancer	9.77e-05	0.00406	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—TP53—rectum cancer	9.62e-05	0.004	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—HRAS—rectum cancer	9.51e-05	0.00396	CbGpPWpGaD
Doxorubicin—ABCB1—female reproductive system—rectum cancer	9.32e-05	0.000898	CbGeAlD
Doxorubicin—AURKA—Cell Cycle, Mitotic—TYMS—rectum cancer	9.29e-05	0.00387	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	9.22e-05	0.00384	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	8.99e-05	0.00374	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	8.93e-05	0.00372	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—NRAS—rectum cancer	8.85e-05	0.00368	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—KRAS—rectum cancer	8.76e-05	0.00364	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—KRAS—rectum cancer	8.64e-05	0.0036	CbGpPWpGaD
Doxorubicin—ABCB1—vagina—rectum cancer	8.43e-05	0.000812	CbGeAlD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—TP53—rectum cancer	8.37e-05	0.00348	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TYMS—rectum cancer	8.31e-05	0.00346	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ITGA2—rectum cancer	8.18e-05	0.0034	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	8.17e-05	0.0034	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—rectum cancer	7.97e-05	0.00332	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—NRAS—rectum cancer	7.96e-05	0.00331	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	7.94e-05	0.0033	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—HRAS—rectum cancer	7.74e-05	0.00322	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—TP53—rectum cancer	7.68e-05	0.0032	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—KRAS—rectum cancer	7.62e-05	0.00317	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—NRAS—rectum cancer	7.52e-05	0.00313	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—HRAS—rectum cancer	7.45e-05	0.0031	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TP53—rectum cancer	7.26e-05	0.00302	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—TYMS—rectum cancer	7.04e-05	0.00293	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	6.94e-05	0.00289	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—KRAS—rectum cancer	6.85e-05	0.00285	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	6.75e-05	0.00281	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—rectum cancer	6.48e-05	0.00269	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—KRAS—rectum cancer	6.47e-05	0.00269	CbGpPWpGaD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	6.33e-05	0.00263	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TYMS—rectum cancer	6.3e-05	0.00262	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—TYMS—rectum cancer	6.06e-05	0.00252	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—TYMS—rectum cancer	6.06e-05	0.00252	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—rectum cancer	5.83e-05	0.00242	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TP53—rectum cancer	5.7e-05	0.00237	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—TYMS—rectum cancer	5.69e-05	0.00237	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—HRAS—rectum cancer	5.5e-05	0.00229	CbGpPWpGaD
Doxorubicin—ABCB1—lymph node—rectum cancer	5.45e-05	0.000525	CbGeAlD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—TYMS—rectum cancer	4.92e-05	0.00205	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	4.92e-05	0.00205	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	4.86e-05	0.00202	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—TYMS—rectum cancer	4.84e-05	0.00201	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—TP53—rectum cancer	4.74e-05	0.00197	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—TYMS—rectum cancer	4.52e-05	0.00188	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TYMS—rectum cancer	4.4e-05	0.00183	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	4.18e-05	0.00174	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—NRAS—rectum cancer	3.92e-05	0.00163	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	3.8e-05	0.00158	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—KRAS—rectum cancer	3.38e-05	0.00141	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	3.37e-05	0.0014	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	3.35e-05	0.00139	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—rectum cancer	3.24e-05	0.00135	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—rectum cancer	3e-05	0.00125	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—NRAS—rectum cancer	2.96e-05	0.00123	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HRAS—rectum cancer	2.87e-05	0.00119	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—rectum cancer	2.76e-05	0.00115	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—TYMS—rectum cancer	2.64e-05	0.0011	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—KRAS—rectum cancer	2.55e-05	0.00106	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—TYMS—rectum cancer	2.54e-05	0.00106	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—TYMS—rectum cancer	2.36e-05	0.000984	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NRAS—rectum cancer	2.3e-05	0.000956	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—rectum cancer	2.26e-05	0.000942	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—rectum cancer	2.17e-05	0.000901	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TYMS—rectum cancer	2.15e-05	0.000894	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—rectum cancer	2.09e-05	0.000869	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—KRAS—rectum cancer	1.98e-05	0.000823	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NRAS—rectum cancer	1.9e-05	0.00079	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—rectum cancer	1.76e-05	0.000731	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TYMS—rectum cancer	1.74e-05	0.000725	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—rectum cancer	1.68e-05	0.000699	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TYMS—rectum cancer	1.67e-05	0.000695	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NRAS—rectum cancer	1.66e-05	0.000692	CbGpPWpGaD
Doxorubicin—NOS1—Disease—KRAS—rectum cancer	1.63e-05	0.00068	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—rectum cancer	1.46e-05	0.000608	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NRAS—rectum cancer	1.43e-05	0.000596	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KRAS—rectum cancer	1.43e-05	0.000596	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—rectum cancer	1.39e-05	0.000578	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NRAS—rectum cancer	1.32e-05	0.000548	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TYMS—rectum cancer	1.31e-05	0.000545	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—rectum cancer	1.27e-05	0.00053	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TYMS—rectum cancer	1.27e-05	0.000527	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	1.25e-05	0.00052	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KRAS—rectum cancer	1.23e-05	0.000513	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—rectum cancer	1.22e-05	0.000506	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TYMS—rectum cancer	1.15e-05	0.000479	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KRAS—rectum cancer	1.13e-05	0.000471	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NRAS—rectum cancer	1.11e-05	0.000463	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	1.11e-05	0.000462	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—rectum cancer	1.05e-05	0.000436	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—rectum cancer	9.63e-06	0.000401	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—rectum cancer	9.57e-06	0.000398	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—rectum cancer	9.22e-06	0.000384	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TYMS—rectum cancer	8.45e-06	0.000351	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—rectum cancer	8.14e-06	0.000339	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—rectum cancer	7.94e-06	0.00033	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—rectum cancer	7.79e-06	0.000324	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—rectum cancer	7.05e-06	0.000293	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—rectum cancer	6.78e-06	0.000282	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—rectum cancer	6.75e-06	0.000281	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—rectum cancer	6.71e-06	0.000279	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TYMS—rectum cancer	6.23e-06	0.000259	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—rectum cancer	5.96e-06	0.000248	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TYMS—rectum cancer	5.87e-06	0.000244	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—rectum cancer	5.83e-06	0.000243	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—rectum cancer	5.7e-06	0.000237	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—rectum cancer	4.96e-06	0.000206	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TYMS—rectum cancer	3.84e-06	0.00016	CbGpPWpGaD
